Literature DB >> 3828485

Plasma concentrations and bioavailability of propranolol by oral, rectal, and intravenous administration in man.

E Cid, F Mella, L Lucchini, M Cárcamo, J Monasterio.   

Abstract

Eight normal male volunteers received 80 mg doses of propranolol by the oral and rectal routes and 2.2 mg by intravenous administration in a crossover fashion. Plasma concentrations of propranolol were measured by a gas chromatographic method using an electron capture detector. Individual subject concentration-time data were analysed and results indicated that the data fit a two compartment model with first order absorption. An approximately two-fold higher plasma propranolol concentration was observed after rectal administration as compared with oral dosing. Statistical analysis of the difference in the total AUCs indicates a significantly higher bioavailability of propranolol administered by the rectal route. The reduced bioavailability after oral administration indicates a substantial first pass effect but that it is possible to bypass the liver, at least partially, by giving the drug rectally to man.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3828485     DOI: 10.1002/bdd.2510070605

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  14 in total

Review 1.  Pharmacokinetics of rectal drug administration, Part II. Clinical applications of peripherally acting drugs, and conclusions.

Authors:  E J van Hoogdalem; A G de Boer; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

2.  Incorporation of the Time-Varying Postprandial Increase in Splanchnic Blood Flow into a PBPK Model to Predict the Effect of Food on the Pharmacokinetics of Orally Administered High-Extraction Drugs.

Authors:  Rachel H Rose; David B Turner; Sibylle Neuhoff; Masoud Jamei
Journal:  AAPS J       Date:  2017-05-19       Impact factor: 4.009

3.  Preparation and evaluation of a novel buccal adhesive system.

Authors:  K Gh Desai; T Mp Kumar
Journal:  AAPS PharmSciTech       Date:  2004-04-29       Impact factor: 3.246

4.  The relative bioavailability of metoprolol following oral and rectal administration to volunteers and patients.

Authors:  F M de Stoppelaar; L M Stolk; A J Beysens; J L Stappers; A P Gorgels
Journal:  Pharm World Sci       Date:  1999-10

5.  The influence of sodium carboxymethylcellulose on drug release from polyethylene oxide extended release matrices.

Authors:  Dasha Palmer; Marina Levina; Ali Nokhodchi; Dennis Douroumis; Tom Farrell; Ali Rajabi-Siahboomi
Journal:  AAPS PharmSciTech       Date:  2011-06-28       Impact factor: 3.246

6.  Formulation, evaluation, and comparison of bilayered and multilayered mucoadhesive buccal devices of propranolol hydrochloride.

Authors:  Vishnu M Patel; Bhupendra G Prajapati; Madhabhai M Patel
Journal:  AAPS PharmSciTech       Date:  2007-03-16       Impact factor: 3.246

7.  Erythrocytes as barriers for drug elimination in the isolated rat liver. II. Propranolol.

Authors:  H J Lee; W L Chiou
Journal:  Pharm Res       Date:  1989-10       Impact factor: 4.200

8.  Mucoadhesive bilayer tablets of propranolol hydrochloride.

Authors:  Vishnu M Patel; Bhupendra G Prajapati; Harsha V Patel; Karshanbhi M Patel
Journal:  AAPS PharmSciTech       Date:  2007-09-21       Impact factor: 3.246

9.  Formulation and development of floating capsules of celecoxib: in vitro and in vivo evaluation.

Authors:  Javed Ali; Shweta Arora; Alka Ahuja; Anil K Babbar; Rakesh K Sharma; Roop K Khar
Journal:  AAPS PharmSciTech       Date:  2007-12-28       Impact factor: 3.246

10.  Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.

Authors:  Josée Bouchard; Greene Shepherd; Robert S Hoffman; Sophie Gosselin; Darren M Roberts; Yi Li; Thomas D Nolin; Valéry Lavergne; Marc Ghannoum
Journal:  Crit Care       Date:  2021-06-10       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.